Why AbbVie Inc.'s $21 Billion Deal Had To Happen
AbbVie Inc has agreed to pay $21 billion to acquire Pharmacyclics, Inc.
3 Little-Known Stocks I'm Glad I Bought
Ophthotech Corp, Portola Pharmaceuticals Inc., and Insys Therapeutics Inc., have been top performers this past year.
Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters?
Pfizer Inc. continues to adjust its R&D spending to offset slipping sales.
2 Tiny Biotechs That Could Have Blockbuster Opportunity
Got risk tolerance? Check out these two small cap biotechs with huge potential.
3 Prevailing Myths About Dividend Stocks
If you invest in dividend stocks, here are three popular myths you need to learn the truth about